Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors
莫那珠单抗联合度伐利尤单抗治疗晚期实体瘤患者的1/2期研究
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2023-007340
Patel, Sandip P; Alonso-Gordoa, Teresa; Banerjee, Susana; Wang, Ding; Naidoo, Jarushka; Standifer, Nathan E; Palmer, Doug C; Cheng, Lin-Yang; Kourtesis, Panagiotis; Ascierto, Maria L; Das, Mayukh; Diamond, Jennifer R; Hellmann, Matthew D; Carneiro, Benedito A